Cambridge, UK - The largest study so far to evaluate CRP as a risk factor for heart disease suggests that that this marker may be not as good a predictor of future cardiac events as was previously ...
Evaluating the clinical utility of circulating tumor cells (CTC) profiling to predict selection of preferred therapeutic regimens in newly diagnosed or pretreated refractory renal cell carcinomas (RCC ...
Analysis of Predictive Biomarkers in Patients With Lung Adenocarcinoma From Southern Brazil Reveals a Distinct Profile From Other Regions of the Country Various mechanisms, including infections, drug ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
Background: An increasing body of evidence links atrial fibrillation (AF) to the inflammatory state. It has been suggested that increased C-reactive protein (CRP) levels are associated with greater ...
Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.
Patients with COPD exacerbations are often treated with antibiotics. There are no clear biomarkers to determine which patients will benefit from these therapies, though. A management strategy using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results